Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

3.04
Data as of Sep 19
 -0.15 / -4.70%
Today’s Change
2.88
Today|||52-Week Range
6.70
-45.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$302.4M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:

Employees

Shareholders

Mutual fund holders19.17%
Other institutional11.68%
Individual stakeholders1.66%

Top Executives

Gary S. JacobChairman, President & Chief Executive Officer
Bernard F. DenoyerSecretary, SVP-Finance & Head-Investor Relations
Kunwar ShailubhaiChief Scientific Officer & Executive VP
Patrick H. GriffinChief Medical Officer
Stephen ComiskeyVice President-Product Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.